The discovery of inhibitors of the NF-κB pathway is of major interest for various viral infections and pathologies such as cancers and autoimmune diseases, which are often associated with constitutive activation of NF-κB responsible for the expression of anti-apoptotic genes and the production of proinflammatory cytokines responsible for pathogenic lesions. This evidence concerns the gene NFKB1 and autoimmune disease.